Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles For Members Only Third Point Posts Loss — And Reveals Four New Bets That Become Top Holdings Stephen Taub For Members Only RA Capital Management, Janus Henderson, Balyasny Back Reverse Merger of Biotech Company Stephen Taub The Evolving Role of PE in Portfolios Sponsored by Dawson Partners